HHS-OIG Declines Sanctions on Diabetes Patient Program Subsidizing Medicare Cost-Sharing
Highlights
The HHS-OIG released a favorable opinion on a patient assistance program (PAP) run by a nonprofit that subsidizes Medicare Part D cost-sharing obligations for diabetes treatments
The agency determined low risks for fraud and abuse as the PAP was not controlled or influenced by pharma, would not steer patients to a particular treatment or pharmacy, and would not lead to overutilization or increased costs to federal healthcare programs
The opinion demonstrates the agency’s recognition that such PAPs provide important assistance to patients
The U.S. Department of Health and Human Services’ Office of Inspector General (HHS-OIG) has issued Advisory Opinion 24-07, a favorable opinion regarding a nonprofit’s patient assistance program (PAP) for diabetes prescription drugs.
Keep Up to Date in a Changing World
